CA Stock MarketDetailed Quotes

RVX Resverlogix Corp

Watchlist
  • 0.060
  • 0.0000.00%
15min DelayMarket Closed Jan 17 16:00 ET
16.84MMarket Cap-1.11P/E (TTM)

About Resverlogix Corp Company

Resverlogix Corp clinical-stage biotechnology company. The company is developing apabetalone (RVX-208), a first-in-class, small molecule that is a selective BET (bromodomain and extra terminal) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. Apabetalone is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. This selective inhibition of apabetalone on BD2 produces a specific set of biological effects with potentially important benefits for patients with chronic disease including cardiovascular disease (CVD) and associated comorbidities, and COVID-19.

Company Profile

SymbolRVX
Company NameResverlogix Corp
Founded2000
MarketTSE
Employees18
Fiscal Year Ends12-31
Address4820 Richard Road South West Suite 300
CityCalgary
CountryCAN
Zip CodeT3E 6L1
Phone+1 403 254-9252

Company Executives

  • Name
  • Position
  • Salary
  • Donald J. McCaffrey
  • Chairman of the Board, President, Secretary and Chief Executive Officer
  • --
  • A. Brad Cann, C.A.,C.P.A.
  • Chief Financial Officer
  • --
  • Dr. Ewelina Kulikowski, PhD
  • Chief Scientific Officer
  • --
  • Dr. Michael Sweeney,M.D.
  • Senior Vice President, Clinical Development
  • --
  • Kenneth J. Zuerblis
  • Independent Director
  • --
  • Kelly McNeill, B.Comm.,C.A.
  • Independent Director
  • --
  • Siu Lun To
  • Independent Director
  • --
Trending CA Stocks
Dividend Kings of Canada Dividend Kings of Canada

Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility. Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility.